CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
- Type
- Retraction
- Notice date
- 5/10/2021 0:00
- Journal
- Frontiers in Oncology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fonc.2021.694036
- Original paper DOI
- 10.3389/fonc.2020.01529